Literature DB >> 4353776

Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.

D C Kem, M H Weinberger, C Gomez-Sanchez, N J Kramer, R Lerman, S Furuyama, C A Nugent.   

Abstract

Plasma aldosterone, cortisol, and renin activity were measured in nine recumbent patients with hyperaldosteronism, including seven with adenomas, one with idiopathic hyperplasia, and one with glucocorticoid suppressible hyperplasia. All had peak values of plasma aldosterone concentration from 3 a.m. to noon and lowest values at 6 p.m. or midnight. This rhythm was similar to the circadian pattern of plasma cortisol in the same patients. When these data were normalized to eliminate the wide variation in ranges of plasma aldosterone and cortisol between individuals, there was an excellent correlation (r = + 0.87, P < 0.005) between the two hormones. In contrast, plasma aldosterone concentrations did not correlate with plasma renin activity before or after normalization of data. Short term suppression of ACTH by administration of dexamethasone eliminated the circadian variation of plasma aldosterone in both patients with hyperplasia and in four of five patients with adenomas, while it markedly altered the rhythm in the fifth. Similar doses of dexamethasone were administered to four normal subjects and did not flatten the circadian rhythm of plasma aldosterone. These data suggest that patients with primary aldosteronism have a circadian rhythm of plasma aldosterone mediated by changes in ACTH.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4353776      PMCID: PMC333030          DOI: 10.1172/JCI107414

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma.

Authors:  P E Slaton; M Schambelan; E G Biglieri
Journal:  J Clin Endocrinol Metab       Date:  1969-02       Impact factor: 5.958

2.  Aldosterone production after suppression of corticotropic secretory activity.

Authors:  R F Spark; S J Gordon; S L Dale; J C Melby
Journal:  Arch Intern Med       Date:  1968-11

3.  Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.

Authors:  M A Newton; J H Laragh
Journal:  J Clin Endocrinol Metab       Date:  1968-07       Impact factor: 5.958

4.  Effects of glucocorticoid administration on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism.

Authors:  M A Newton; J H Laragh
Journal:  J Clin Endocrinol Metab       Date:  1968-07       Impact factor: 5.958

5.  A diurnal rhythm in plasma renin activity in man.

Authors:  R D Gordon; L K Wolfe; D P Island; G W Liddle
Journal:  J Clin Invest       Date:  1966-10       Impact factor: 14.808

6.  Effect of posture on the metabolic clearance rate, plasma concentration and blood production rate of aldosterone in man.

Authors:  H M Balikian; A H Brodie; S L Dale; J C Melby; J F Tait
Journal:  J Clin Endocrinol Metab       Date:  1968-11       Impact factor: 5.958

7.  Preoperative diagnosis of primary aldosteronism, including a comparison of operative findings and preoperative tumor localization by adrenal phlebography.

Authors:  J W Conn; D R Rovner; E L Cohen; J J Bookstein; J C Cerny; C P Lucas
Journal:  Arch Intern Med       Date:  1969-02

8.  Plasma corticosteroids determined by use of corticosteroid-binding globulin and dextran-coated charcoal.

Authors:  C A Nugent; D M Mayes
Journal:  J Clin Endocrinol Metab       Date:  1966-10       Impact factor: 5.958

9.  The effect of acute haemorrhage in the dog and man on plasma-renin concentration.

Authors:  J J Brown; D L Davies; A F Lever; J I Robertson; A Verniory
Journal:  J Physiol       Date:  1966-02       Impact factor: 5.182

10.  CORRELATION OF PLASMA ACTH CONCENTRATION WITH ADRENOCORTICAL RESPONSE IN NORMAL HUMAN SUBJECTS, SURGICAL PATIENTS, AND PATIENTS WITH CUSHING'S DISEASE.

Authors:  R L NEY; N SHIMIZU; W E NICHOLSON; D P ISLAND; G W LIDDLE
Journal:  J Clin Invest       Date:  1963-11       Impact factor: 14.808

View more
  16 in total

1.  Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.

Authors:  H Vetter; W Vetter
Journal:  Klin Wochenschr       Date:  1975-04-15

2.  Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.

Authors:  R M Carey; C R Ayers; E D Vaughan; M J Peach; S M Herf
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

3.  Clinical and biochemical features of patients with aldosterone-producing adenoma and idiopathic hyperaldosteronism.

Authors:  H Witzgall; O A Müller; P C Weber
Journal:  Klin Wochenschr       Date:  1983-01-03

4.  Responses of plasma renin activity and dopamine-beta-hydroxylase to increased intravascular volume.

Authors:  F Lamprecht; W L Miller; T Kawasaki; F C Bartter
Journal:  J Neural Transm       Date:  1979       Impact factor: 3.575

5.  [Diurnal profiles of plasma aldosterone, cortisol, renin, angiotensinogen and angiotensinases in normal subjects (author's transl)].

Authors:  D Lommer; A Distler; H P Nast; K Sinterhauf; U Walter; H P Wolff; K Sieler
Journal:  Klin Wochenschr       Date:  1976-02-01

6.  Intravenous administration of ghrelin increases serum cortisol and aldosterone concentrations in heavy-drinking alcohol-dependent individuals: Results from a double-blind, placebo-controlled human laboratory study.

Authors:  Carolina L Haass-Koffler; Victoria M Long; Mehdi Farokhnia; Molly Magill; George A Kenna; Robert M Swift; Lorenzo Leggio
Journal:  Neuropharmacology       Date:  2019-07-13       Impact factor: 5.250

Review 7.  Cellular origin of aldosteronomas.

Authors:  A Ganguly
Journal:  Clin Investig       Date:  1992-05

Review 8.  Progress in primary aldosteronism: present challenges and perspectives.

Authors:  C E Gomez-Sanchez; G P Rossi; F Fallo; M Mannelli
Journal:  Horm Metab Res       Date:  2010-01-20       Impact factor: 2.936

9.  Nocturnal blood pressure in normotensive subjects and those with white coat, primary, and secondary hypertension.

Authors:  M Middeke; J Schrader
Journal:  BMJ       Date:  1994-03-05

10.  Diurnal blood pressure pattern in patients with primary aldosteronism.

Authors:  S Zacharieva; M Orbetzova; A Elenkova; A Stoynev; M Yaneva; R Schigarminova; K Kalinov; E Nachev
Journal:  J Endocrinol Invest       Date:  2006-01       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.